Cassava Sciences Inc vs T-Rex 2X Long MSTR Daily Target ETF — how do they compare? Cassava Sciences Inc trades at $1.06 (market cap $53.14M), while T-Rex 2X Long MSTR Daily Target ETF trades at $1.89. Which is the better fit depends on your goals.
| FLNA | MSTU | |
|---|---|---|
Market Cap | $53.14M | — |
Sector | Health | Leveraged / Inverse |
52-Week High | $4.64 | $106.80 |
52-Week Low | $1.09 | $1.46 |
Enterprise Value | -$33.43M | — |
Signals from Pluang's Aura AI — not financial advice
FLNA trades at $1.06, down 2.75% today, with a bearish technical signal from moving averages but neutral oscillators. The stock shows a low P/B of 0.78, yet profitability metrics are negative, including a -79.59% ROE and -$90.97M net income for 2025. Recent Q1 2026 earnings beat expectations, and analyst consensus is 66.7% buy. News highlights Q1 financial results and a scientific presentation on TSC-related epilepsy therapies.
Outlook remains speculative due to persistent losses and negative cash flows, offset by strong analyst support and recent earnings beats. Key risks include funding needs for drug development and competitive pressures, while potential upside hinges on clinical progress in TSC-related epilepsy treatments.
MSTU trades at $1.845, down 6.82% in the last session, reflecting significant volatility. Technical indicators show a bearish moving average signal but neutral oscillators, with key support and resistance clustered at $2. Financial ratios are unavailable, and recent news highlights extreme losses, including a 98% decline from November 2024 levels per 24/7 Wall Street on 2026-06-11.
The outlook remains highly speculative with substantial downside risk due to leveraged exposure to MicroStrategy's performance. Investors face potential for rapid erosion of capital amid volatility, while any recovery hinges on MicroStrategy's stock rebound. Caution is warranted given the fund's track record of severe losses.
Trailing returns across standard periods
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease
Read more on FLNA →MSTU is a leveraged ETF that seeks daily investment results corresponding to 200% of the daily performance of the MicroStrategy Incorporated (MSTR) stock. It is designed as a tactical tool for experienced traders to take a bullish (long) position in MSTR, a company known for its significant Bitcoin holdings. Due to the effects of compounding and leverage, the ETF is intended to be held for a single day and is not suitable for long-term investment.
Read more on MSTU →